ImmuCell Corporation Short-term Debt, Average Outstanding Amount
ImmuCell Corporation (ICCC) reported Short-term Debt, Average Outstanding Amount of $1.00 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Debt
us-gaap:ShorttermDebtAverageOutstandingAmount · last filed 2024-08-13
- ImmuCell Corporation short-term debt, average outstanding amount for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation short-term debt, average outstanding amount for the quarter ending 2024-03-31 was $1.00M, a 0.00% change year-over-year.
- ImmuCell Corporation short-term debt, average outstanding amount for the quarter ending 2023-12-31 was $0.00.
- ImmuCell Corporation short-term debt, average outstanding amount for the quarter ending 2023-09-30 was $1.00M, a 0.00% change year-over-year.
- ImmuCell Corporation short-term debt, average outstanding amount for fiscal 2021 was $1.00M, a 0.00% change from fiscal 2020.
- ImmuCell Corporation short-term debt, average outstanding amount for fiscal 2020 was $1.00M.
| Period end | Short-term Debt, Average Outstanding Amount 3 month | Short-term Debt, Average Outstanding Amount 6 month | Short-term Debt, Average Outstanding Amount 9 month | Short-term Debt, Average Outstanding Amount 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.00M 10-Q · filed 2024-08-13 | $1.00M derived: sum of 3 quarters · filed 2024-08-13 | $2.00M derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-14 | $1.00M derived: sum of 2 quarters · filed 2024-05-14 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $3.00M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-05-14 | $1.00M derived: sum of 2 quarters · filed 2024-05-14 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $1.00M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $1.00M 10-Q · filed 2023-11-13 | $2.00M derived: sum of 2 quarters · filed 2023-11-13 | $1.00M 10-Q · filed 2023-11-13 | $3.00M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-10 | $1.00M 10-Q · filed 2024-08-13 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $3.00M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-14 | $1.00M derived: sum of 2 quarters · filed 2024-05-14 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $3.00M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-05-14 | $1.00M derived: sum of 2 quarters · filed 2024-05-14 | $2.00M derived: sum of 3 quarters · filed 2024-05-14 | $1.00M 10-Q · filed 2024-05-14 |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-13 | $2.00M derived: sum of 2 quarters · filed 2023-11-13 | $1.00M 10-Q · filed 2023-11-13 | $3.00M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-10 | $1.00M 10-Q · filed 2023-08-10 | $2.00M derived: sum of 3 quarters · filed 2023-08-10 | $2.00M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-11 | $1.00M derived: sum of 2 quarters · filed 2023-05-11 | $1.00M derived: sum of 3 quarters · filed 2023-05-11 | $1.00M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $1.00M 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $1.00M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.00M 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | $1.00M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |